ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PD-1/PD-L1 Checkpoint Inhibitors Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-0L18747
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global PD 1 PD L1 Checkpoint Inhibitors Market Research Report 2024
BUY CHAPTERS

Global PD-1/PD-L1 Checkpoint Inhibitors Market Research Report 2024

Code: QYRE-Auto-0L18747
Report
October 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Merck
Regeneron Pharmaceuticals
Roche
Pfizer Inc
Astrazeneca plc
Hengrui Pharmaceuticals
Junshi Biosciences

PD-1/PD-L1 Checkpoint Inhibitors Market

PD-1/PD-L1 checkpoint inhibitors are a type of cancer immunotherapy that work by blocking the interaction between programmed cell death protein 1 (PD-1) on T cells and its ligand PD-L1 on tumor cells.By inhibiting this pathway, these therapies enhance the immune system's ability to recognize and attack cancer cells, making them effective in treating various cancers, including melanoma and non-small cell lung cancer.
The global PD-1/PD-L1 Checkpoint Inhibitors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for PD-1/PD-L1 Checkpoint Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PD-1/PD-L1 Checkpoint Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of PD-1/PD-L1 Checkpoint Inhibitors include Bristol Myers Squibb, Merck, Regeneron Pharmaceuticals, Roche, Pfizer, AstraZeneca, Hengrui Pharmaceuticals, Junshi Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PD-1/PD-L1 Checkpoint Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-1/PD-L1 Checkpoint Inhibitors.
The PD-1/PD-L1 Checkpoint Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global PD-1/PD-L1 Checkpoint Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PD-1/PD-L1 Checkpoint Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of PD-1/PD-L1 Checkpoint Inhibitors Market Report

Report Metric Details
Report Name PD-1/PD-L1 Checkpoint Inhibitors Market
Segment by Type
  • PD-1 Inhibitors
  • PD-L1 Inhibitors
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bristol Myers Squibb, Merck, Regeneron Pharmaceuticals, Roche, Pfizer, AstraZeneca, Hengrui Pharmaceuticals, Junshi Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of PD-1/PD-L1 Checkpoint Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of PD-1/PD-L1 Checkpoint Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the PD-1/PD-L1 Checkpoint Inhibitors Market report?

Ans: The main players in the PD-1/PD-L1 Checkpoint Inhibitors Market are Bristol Myers Squibb, Merck, Regeneron Pharmaceuticals, Roche, Pfizer, AstraZeneca, Hengrui Pharmaceuticals, Junshi Biosciences

What are the Application segmentation covered in the PD-1/PD-L1 Checkpoint Inhibitors Market report?

Ans: The Applications covered in the PD-1/PD-L1 Checkpoint Inhibitors Market report are Squamous Cell Skin Cancer, Non-small Cell Lung Cancer, Melanoma, Gastric Cancer, Other

What are the Type segmentation covered in the PD-1/PD-L1 Checkpoint Inhibitors Market report?

Ans: The Types covered in the PD-1/PD-L1 Checkpoint Inhibitors Market report are PD-1 Inhibitors, PD-L1 Inhibitors

Recommended Reports

Cancer Immunotherapy

Cancer Inhibitors

Lung Cancer Therapy

1 PD-1/PD-L1 Checkpoint Inhibitors Market Overview
1.1 Product Definition
1.2 PD-1/PD-L1 Checkpoint Inhibitors by Type
1.2.1 Global PD-1/PD-L1 Checkpoint Inhibitors Market Value Comparison by Type (2024-2030)
1.2.2 PD-1 Inhibitors
1.2.3 PD-L1 Inhibitors
1.3 PD-1/PD-L1 Checkpoint Inhibitors by Application
1.3.1 Global PD-1/PD-L1 Checkpoint Inhibitors Market Value by Application (2024-2030)
1.3.2 Squamous Cell Skin Cancer
1.3.3 Non-small Cell Lung Cancer
1.3.4 Melanoma
1.3.5 Gastric Cancer
1.3.6 Other
1.4 Global PD-1/PD-L1 Checkpoint Inhibitors Market Size Estimates and Forecasts
1.4.1 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue 2019-2030
1.4.2 Global PD-1/PD-L1 Checkpoint Inhibitors Sales 2019-2030
1.4.3 Global PD-1/PD-L1 Checkpoint Inhibitors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 PD-1/PD-L1 Checkpoint Inhibitors Market Competition by Manufacturers
2.1 Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Manufacturers (2019-2024)
2.2 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global PD-1/PD-L1 Checkpoint Inhibitors Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of PD-1/PD-L1 Checkpoint Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PD-1/PD-L1 Checkpoint Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PD-1/PD-L1 Checkpoint Inhibitors, Product Type & Application
2.7 Global Key Manufacturers of PD-1/PD-L1 Checkpoint Inhibitors, Date of Enter into This Industry
2.8 Global PD-1/PD-L1 Checkpoint Inhibitors Market Competitive Situation and Trends
2.8.1 Global PD-1/PD-L1 Checkpoint Inhibitors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest PD-1/PD-L1 Checkpoint Inhibitors Players Market Share by Revenue
2.8.3 Global PD-1/PD-L1 Checkpoint Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global PD-1/PD-L1 Checkpoint Inhibitors Market Scenario by Region
3.1 Global PD-1/PD-L1 Checkpoint Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Region: 2019-2030
3.2.1 Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Region: 2019-2024
3.2.2 Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Region: 2025-2030
3.3 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue by Region: 2019-2030
3.3.1 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue by Region: 2019-2024
3.3.2 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue by Region: 2025-2030
3.4 North America PD-1/PD-L1 Checkpoint Inhibitors Market Facts & Figures by Country
3.4.1 North America PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2019-2030)
3.4.3 North America PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe PD-1/PD-L1 Checkpoint Inhibitors Market Facts & Figures by Country
3.5.1 Europe PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2019-2030)
3.5.3 Europe PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Facts & Figures by Region
3.6.1 Asia Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales by Region (2019-2030)
3.6.3 Asia Pacific PD-1/PD-L1 Checkpoint Inhibitors Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America PD-1/PD-L1 Checkpoint Inhibitors Market Facts & Figures by Country
3.7.1 Latin America PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2019-2030)
3.7.3 Latin America PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2019-2030)
3.8.3 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2019-2030)
4.1.1 Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2019-2024)
4.1.2 Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2025-2030)
4.1.3 Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Type (2019-2030)
4.2 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue by Type (2019-2030)
4.2.1 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue by Type (2019-2024)
4.2.2 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue by Type (2025-2030)
4.2.3 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Type (2019-2030)
4.3 Global PD-1/PD-L1 Checkpoint Inhibitors Price by Type (2019-2030)
5 Segment by Application
5.1 Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2019-2030)
5.1.1 Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2019-2024)
5.1.2 Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2025-2030)
5.1.3 Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Application (2019-2030)
5.2 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue by Application (2019-2030)
5.2.1 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue by Application (2019-2024)
5.2.2 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue by Application (2025-2030)
5.2.3 Global PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Application (2019-2030)
5.3 Global PD-1/PD-L1 Checkpoint Inhibitors Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Company Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol Myers Squibb PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Regeneron Pharmaceuticals
6.3.1 Regeneron Pharmaceuticals Company Information
6.3.2 Regeneron Pharmaceuticals Description and Business Overview
6.3.3 Regeneron Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Regeneron Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
6.3.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.4 Roche
6.4.1 Roche Company Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Hengrui Pharmaceuticals
6.7.1 Hengrui Pharmaceuticals Company Information
6.7.2 Hengrui Pharmaceuticals Description and Business Overview
6.7.3 Hengrui Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Hengrui Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
6.7.5 Hengrui Pharmaceuticals Recent Developments/Updates
6.8 Junshi Biosciences
6.8.1 Junshi Biosciences Company Information
6.8.2 Junshi Biosciences Description and Business Overview
6.8.3 Junshi Biosciences PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Junshi Biosciences PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
6.8.5 Junshi Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PD-1/PD-L1 Checkpoint Inhibitors Industry Chain Analysis
7.2 PD-1/PD-L1 Checkpoint Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PD-1/PD-L1 Checkpoint Inhibitors Production Mode & Process
7.4 PD-1/PD-L1 Checkpoint Inhibitors Sales and Marketing
7.4.1 PD-1/PD-L1 Checkpoint Inhibitors Sales Channels
7.4.2 PD-1/PD-L1 Checkpoint Inhibitors Distributors
7.5 PD-1/PD-L1 Checkpoint Inhibitors Customers
8 PD-1/PD-L1 Checkpoint Inhibitors Market Dynamics
8.1 PD-1/PD-L1 Checkpoint Inhibitors Industry Trends
8.2 PD-1/PD-L1 Checkpoint Inhibitors Market Drivers
8.3 PD-1/PD-L1 Checkpoint Inhibitors Market Challenges
8.4 PD-1/PD-L1 Checkpoint Inhibitors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
Merck
Regeneron Pharmaceuticals
Roche
Pfizer Inc
Astrazeneca plc
Hengrui Pharmaceuticals
Junshi Biosciences
List of Tables
 Table 1. Global PD-1/PD-L1 Checkpoint Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global PD-1/PD-L1 Checkpoint Inhibitors Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global PD-1/PD-L1 Checkpoint Inhibitors Market Competitive Situation by Manufacturers in 2023
 Table 4. Global PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market PD-1/PD-L1 Checkpoint Inhibitors Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of PD-1/PD-L1 Checkpoint Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of PD-1/PD-L1 Checkpoint Inhibitors, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of PD-1/PD-L1 Checkpoint Inhibitors, Product Type & Application
 Table 12. Global Key Manufacturers of PD-1/PD-L1 Checkpoint Inhibitors, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global PD-1/PD-L1 Checkpoint Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1/PD-L1 Checkpoint Inhibitors as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global PD-1/PD-L1 Checkpoint Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Region (2019-2024) & (K Units)
 Table 18. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Region (2019-2024)
 Table 19. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Region (2025-2030) & (K Units)
 Table 20. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Region (2025-2030)
 Table 21. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Region (2019-2024)
 Table 23. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Region (2025-2030)
 Table 25. North America PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2019-2024) & (K Units)
 Table 27. North America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2025-2030) & (K Units)
 Table 28. North America PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2019-2024) & (K Units)
 Table 32. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2025-2030) & (K Units)
 Table 33. Europe PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific PD-1/PD-L1 Checkpoint Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific PD-1/PD-L1 Checkpoint Inhibitors Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific PD-1/PD-L1 Checkpoint Inhibitors Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units) by Type (2019-2024)
 Table 51. Global PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units) by Type (2025-2030)
 Table 52. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Type (2019-2024)
 Table 53. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Type (2025-2030)
 Table 54. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Type (2019-2024)
 Table 57. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Type (2025-2030)
 Table 58. Global PD-1/PD-L1 Checkpoint Inhibitors Price (US$/Unit) by Type (2019-2024)
 Table 59. Global PD-1/PD-L1 Checkpoint Inhibitors Price (US$/Unit) by Type (2025-2030)
 Table 60. Global PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units) by Application (2019-2024)
 Table 61. Global PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units) by Application (2025-2030)
 Table 62. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Application (2019-2024)
 Table 63. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Application (2025-2030)
 Table 64. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Application (2019-2024)
 Table 67. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Application (2025-2030)
 Table 68. Global PD-1/PD-L1 Checkpoint Inhibitors Price (US$/Unit) by Application (2019-2024)
 Table 69. Global PD-1/PD-L1 Checkpoint Inhibitors Price (US$/Unit) by Application (2025-2030)
 Table 70. Bristol Myers Squibb Company Information
 Table 71. Bristol Myers Squibb Description and Business Overview
 Table 72. Bristol Myers Squibb PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Bristol Myers Squibb PD-1/PD-L1 Checkpoint Inhibitors Product
 Table 74. Bristol Myers Squibb Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Merck PD-1/PD-L1 Checkpoint Inhibitors Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Regeneron Pharmaceuticals Company Information
 Table 81. Regeneron Pharmaceuticals Description and Business Overview
 Table 82. Regeneron Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Regeneron Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Product
 Table 84. Regeneron Pharmaceuticals Recent Developments/Updates
 Table 85. Roche Company Information
 Table 86. Roche Description and Business Overview
 Table 87. Roche PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Roche PD-1/PD-L1 Checkpoint Inhibitors Product
 Table 89. Roche Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Pfizer PD-1/PD-L1 Checkpoint Inhibitors Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. AstraZeneca Company Information
 Table 96. AstraZeneca Description and Business Overview
 Table 97. AstraZeneca PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. AstraZeneca PD-1/PD-L1 Checkpoint Inhibitors Product
 Table 99. AstraZeneca Recent Developments/Updates
 Table 100. Hengrui Pharmaceuticals Company Information
 Table 101. Hengrui Pharmaceuticals Description and Business Overview
 Table 102. Hengrui Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Hengrui Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Product
 Table 104. Hengrui Pharmaceuticals Recent Developments/Updates
 Table 105. Junshi Biosciences Company Information
 Table 106. Junshi Biosciences Description and Business Overview
 Table 107. Junshi Biosciences PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Junshi Biosciences PD-1/PD-L1 Checkpoint Inhibitors Product
 Table 109. Junshi Biosciences Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. PD-1/PD-L1 Checkpoint Inhibitors Distributors List
 Table 113. PD-1/PD-L1 Checkpoint Inhibitors Customers List
 Table 114. PD-1/PD-L1 Checkpoint Inhibitors Market Trends
 Table 115. PD-1/PD-L1 Checkpoint Inhibitors Market Drivers
 Table 116. PD-1/PD-L1 Checkpoint Inhibitors Market Challenges
 Table 117. PD-1/PD-L1 Checkpoint Inhibitors Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of PD-1/PD-L1 Checkpoint Inhibitors
 Figure 2. Global PD-1/PD-L1 Checkpoint Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global PD-1/PD-L1 Checkpoint Inhibitors Market Share by Type: 2023 & 2030
 Figure 4. PD-1 Inhibitors Product Picture
 Figure 5. PD-L1 Inhibitors Product Picture
 Figure 6. Global PD-1/PD-L1 Checkpoint Inhibitors Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global PD-1/PD-L1 Checkpoint Inhibitors Market Share by Application: 2023 & 2030
 Figure 8. Squamous Cell Skin Cancer
 Figure 9. Non-small Cell Lung Cancer
 Figure 10. Melanoma
 Figure 11. Gastric Cancer
 Figure 12. Other
 Figure 13. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global PD-1/PD-L1 Checkpoint Inhibitors Market Size (2019-2030) & (US$ Million)
 Figure 15. Global PD-1/PD-L1 Checkpoint Inhibitors Sales (2019-2030) & (K Units)
 Figure 16. Global PD-1/PD-L1 Checkpoint Inhibitors Average Price (US$/Unit) & (2019-2030)
 Figure 17. PD-1/PD-L1 Checkpoint Inhibitors Report Years Considered
 Figure 18. PD-1/PD-L1 Checkpoint Inhibitors Sales Share by Manufacturers in 2023
 Figure 19. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest PD-1/PD-L1 Checkpoint Inhibitors Players: Market Share by Revenue in PD-1/PD-L1 Checkpoint Inhibitors in 2023
 Figure 21. PD-1/PD-L1 Checkpoint Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global PD-1/PD-L1 Checkpoint Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Country (2019-2030)
 Figure 24. North America PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Country (2019-2030)
 Figure 25. United States PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Country (2019-2030)
 Figure 28. Europe PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Country (2019-2030)
 Figure 29. Germany PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Region (2019-2030)
 Figure 36. China PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Country (2019-2030)
 Figure 44. Mexico PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE PD-1/PD-L1 Checkpoint Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of PD-1/PD-L1 Checkpoint Inhibitors by Type (2019-2030)
 Figure 54. Global Revenue Market Share of PD-1/PD-L1 Checkpoint Inhibitors by Type (2019-2030)
 Figure 55. Global PD-1/PD-L1 Checkpoint Inhibitors Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of PD-1/PD-L1 Checkpoint Inhibitors by Application (2019-2030)
 Figure 57. Global Revenue Market Share of PD-1/PD-L1 Checkpoint Inhibitors by Application (2019-2030)
 Figure 58. Global PD-1/PD-L1 Checkpoint Inhibitors Price (US$/Unit) by Application (2019-2030)
 Figure 59. PD-1/PD-L1 Checkpoint Inhibitors Value Chain
 Figure 60. PD-1/PD-L1 Checkpoint Inhibitors Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global PD 1 and PDL 1 Inhibitors Market Research Report 2025
Global Immune Checkpoint Inhibitors for Cancer Market Research Report 2024
Pd 1 and Pd L1 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Checkpoint Inhibitors for Treating Cancer Market Insights Forecast to 2030
PD L1 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
PD 1 and PD L1 Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PD 1 Drugs for the Treatment of Cervical Cancer Market Research Report 2025
Global PD L1 Biomarker Testing Platform Market Insights Forecast to 2030
Global ICIs for Cervical Cancer Market Research Report 2025
Global Immune Checkpoint Proteins Market Research Report 2024
Global PD 1 and PD L1 Monoclonal Antibody Market Research Report 2025
Global Anti PD 1 Antibody Market Insights Forecast to 2030
Global CTLA 4 Inhibitors for Cervical Cancer Market Research Report 2024
Global PD L1 Biomarker Testing Market Insights Forecast to 2030
Global PD 1 Inhibitor Market Research Report 2024
Global PD L1 and PIK3CA Testing Market Research Report 2024
Global PD 1 and PD L1 Immunotherapy Market Insights Forecast to 2030
Global Combination Therapies for Melanoma Market Research Report 2024
Global PD 1 and PD L1 Antibody Market Insights Forecast to 2030
Global Cancer Immunotherapies Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions